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Abstract
Virtual reality exposure (VRE) has been shown to be effective for treating a variety of anxiety
disorders, including social phobia. Presence, or the level of connection an individual feels with
the virtual environment, is widely discussed as a critical construct both for the experience of
anxiety within a virtual environment and for a successful response to VRE. Two published
studies show that whereas generalized presence relates to fear ratings during VRE, it does not
relate to treatment response. However, presence has been conceptualized as multidimensional,
with three primary factors (spatial presence, involvement, and realness). These factors can be
linked to other research on the facilitation of fear during exposure, inhibitors of treatment
response (e.g., distraction), and more recent theoretical discussions of the mechanisms of
exposure therapy, such as Bouton’s (2004) description of expectancy violation. As such, one or
more of these components of presence may be more strongly associated with the experience of
fear during VRE and treatment response than the overarching construct. The current study
(N=41) evaluated relations between three theorized components of presence, fear ratings during
VRE, and treatment response for VRE for social phobia. Results suggest that total presence and
realness subscale scores were related to in-session peak fear ratings. However, only scores on
the involvement subscale significantly predicted treatment response. Implications of these
findings are discussed.

Keywords: Social Anxiety; Virtual Reality Exposure; Presence
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Does engagement with exposure yield better outcomes?: Components of presence as a predictor
of treatment response for virtual reality exposure therapy for social phobia
1. Introduction
Virtual Reality Exposure Therapy (VRE) is an effective treatment for a variety of anxiety
disorders, including social phobia (for a review see Parsons & Rizzo, 2008). VRE involves
exposing anxious individuals to virtually-generated feared stimuli. An advantage of VRE relative
to in vivo exposure therapies is the greater ease with which therapists can manipulate the feared
stimuli within the virtual environment (Rothbaum, Hodges, Kooper, & Opdyke, 1995). This
advantage is especially relevant to exposure treatment for social phobia, because in vivo
treatment of social fears (e.g., fear of public speaking) requires recruitment of potentially large
numbers of “audience members” on multiple occasions. Simulation of public speaking scenarios
using virtual environments thus circumvents a significant barrier to treatment (Olfson et al.,
2000).
A handful of studies have demonstrated the utility of VRE for reducing symptoms among
those diagnosed with social phobia and those with high levels of public speaking fears. The
largest study to date examined changes in social fears after 12 sessions of VRE in 18 participants
with social phobia (Klinger et al., 2005). Exposures were conducted in four virtual environments;
these environments replicated different social situations that revolved around performance (e.g.,
public speaking), interpersonal interaction (e.g., a dinner conversation), assertiveness (e.g.,
having a viewpoint challenged), and evaluation (e.g., completing a task while being observed).
Those who received individual VRE demonstrated a comparable decrease in symptoms to those
receiving cognitive behavioral group therapy. Two trials with smaller samples yielded similar
findings. Anderson and colleagues (2005) demonstrated that VRE reduced public speaking fears
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in 10 participants diagnosed with social phobia. VRE also was more effective than no treatment
at reducing public speaking fears in a sample of undergraduates that rated public speaking as a
highly feared situation (Harris, Kemmerling, & North, 2002).
The concept of presence has been identified as a mechanism by which exposure to virtual
stimuli can successfully treat fears in the real world (Parsons & Rizzo, 2008; Regenbrecht,
Schubert, & Friedmann, 1998; Robillard, Bouchard, Fournier, & Renaud, 2003; Rothbaum et al.,
1995; Wiederhold & Wiederhold, 2005). Presence is the extent to which an individual feels
connected to or engaged with a virtual stimulus or environment (Lee, 2004; Schubert,
Friedmann, & Regenbrecht, 2001). Empirical investigations and theoretical models both suggest
that presence is comprised of multiple factors (Lee, 2004; Schubert et al., 2001; Witmer &
Singer, 1998). The first factor, spatial presence, is the feeling that one is physically in the virtual
space. Involvement, the second factor, is the extent to which one keeps attention focused on the
virtual stimulus and ignores competing incongruent information. Realness, or the extent that the
virtual stimulus coincides with expectations of the real stimulus, constitutes the third factor.
Despite the theorized relation between presence and VRE treatment response, there has
been relatively little research on this topic, and results have been underwhelming. Specifically,
two published empirical studies in this area found no significant relations between presence and
response to VRE treatment for specific phobias (Krijn et al., 2004; Price & Anderson, 2007).
Krijn and colleagues (2004) compared treatment response for acrophobia across high- and lowpresence conditions. Researchers manipulated presence by using a complex computerautomated virtual environment (CAVE) which projects the virtual environment on the walls of a
room for the high presence condition and a head mounted display (HMD) for the low presence
condition. Results indicated that treatment response did not differ across high- and low-presence
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conditions. Price and Anderson (2007) reported similar findings in a sample of adults who
received 8 sessions of VRE for fear of flying. Although presence was associated with peak fear
ratings during the first virtual reality exposure therapy session, it did not predict treatment
response.
These null findings as to the relation between presence and treatment response challenge a
basic assumption of VRE – that presence is a mechanism by which exposure therapy works.
From the beginning, VRE researchers linked the concept of presence to the emotion processing
theory (Foa & Kozak, 1986), which posits that a phobic fear structure must be activated through
presentation of a feared stimulus in order for effective exposure therapy to occur. Presence was
conceptualized as the construct that enabled the experience of fear towards a virtual stimulus; it
thus constituted a necessary condition for effective exposure therapy as detailed by emotional
processing theory (Anderson, Rothbaum, & Hodges, 2000). Indeed, the first VRE treatment
outcome studies specifically targeted fears with powerful physical cues (e.g., height) that could
be easily modeled within a virtual environment in order to maximize presence and fear structure
activation (Rothbaum et al., 1995).
However, according to emotional processing theory, activation of the fear structure alone
does not guarantee effective exposure therapy (Foa & Kozak, 1986). According to the emotion
processing theory, effective exposure therapy requires prolonged, repeated, and controlled
exposure to feared stimuli for extinction of fear to occur. Although VRE is described as an ideal
mechanism for exposure therapy because it can be more easily manipulated (e.g., prolonged,
repeated, and controlled) than in vivo exposure, it is still a context that provides only the
potential for extinction learning. As a result, presence has been described as a construct that is
necessary, but not sufficient for obtaining treatment response (Price & Anderson, 2007).
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Examining the distinct factors that compose the construct of “presence” may help clarify
both its potential relation to VRE treatment response and the null findings to date obtained with
global presence measures. For example, the involvement factor reflects attention to the virtual
stimulus, and relates to research showing that distraction from feared stimuli inhibits treatment
response (Grayson, Foa, & Steketee, 1982; Wells & Papageorgiou, 1998). Presumably, greater
involvement with the virtual environment is associated with greater attention to the feared
stimulus, thus enhancing the effectiveness of the virtual environment as a context for extinction
learning.
The realness factor of presence (the extent to which the virtual stimulus coincides with
expectations about the real world stimulus), maps on to the face valid concept of how “real” the
virtual environment feels, and may be important for fear structure activation. It also pertains to
Bouton’s (2004) notion of the importance of expectancy violation in extinction learning.
According to Bouton, exposure therapy provides the opportunity for disconfirmation of
expectations about feared stimuli (e.g., when a college student with social phobia signs up for a
class that includes an oral presentation and finds that she neither fails the assignment nor is
humiliated, and the experience disconfirms her negative expectations). In the context of VRE,
the notion of expectancy violation is particularly interesting. There are likely some expectancies
that cannot be violated in the virtual environment (e.g., there is no chance that the student will
fail a course based on poor performance on a speech in a virtual environment) and other
expectancies that could be violated (e.g., the person does not sound “stupid” while speaking to a
group).
Finally, the spatial presence factor of presence (the extent that the participant feels they are
physically in the virtual environment) has been associated with increased physiological arousal
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after completing goals in an interactive virtual environment (Niklas et al., 2004). For those with
social phobia, interacting with a virtual audience should lead to increased arousal and anxiety.
Of the two prior studies that examined the relation between presence and treatment
response, one study (Price & Anderson, 2007) assessed presence using a unidimensional
measure, and thus did not assess the roles of distinct aspects of the construct. Krijn and
colleagues (2004) did not assess presence directly, but instead manipulated it by assigning
participants to low and high-presence conditions. Notably, a moderate proportion of participants
dropped out or withdrew (n=10) from the low presence condition because it did not arouse
anxiety. Thus, there are theoretical reasons to evaluate the relation between presence, particularly
the factors of presence, and treatment response that have not been adequately examined in the
two studies examining the topic to date.
The current study sought to examine associations between presence, the global construct as
well as its constituent factors (spatial presence, involvement, realness), fear ratings during VRE
for public speaking fears, and treatment response among a clinical sample diagnosed with social
phobia. We hypothesized that the overall score on a self-report measure of presence, as well as
scores on each of the 3 factor subscales would be positively associated with both fear ratings
during VRE sessions and treatment response. A second aim of the study was to replicate prior
research showing that the global construct of presence is related to fear ratings during VRE, and
to extend this research by examining how specific presence factors relate to fear during VRE.
2. Methods
2.1 Participants
Participants were 41 individuals diagnosed with social phobia according to DSM-IV
criteria who were recruited as part of two larger treatment outcome studies. Diagnoses were
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made using the Structured Clinical Interview for the DSM-IV (SCID; First, Gibbon, Spitzer, &
Williams, 2002) by doctoral students that were trained in diagnostic interviewing via training
tapes and practice interviews under the supervision of a licensed clinical psychologist.
Agreement between the clinicians and the trainees on a subsample (20%) of the assessment
interviews was 100%. Approximately 41% (n = 17) met criteria for social phobia: generalized
subtype. The majority of participants did not meet criteria for any comorbid diagnoses (n = 30,
73%). Participants were recruited through newspaper advertisements, posted flyers, and internetbased outlets seeking participants with significant fears of public speaking. To be included in the
study, participants had to be English speakers and to meet DSM-IV criteria for social phobia.
Participants taking psychoactive medication had to have been stabilized on their current
medication(s) and dosage(s) for at least 3 months and were also required to remain at the same
dosage throughout the study. Individuals meeting any of the following criteria were excluded, (a)
history of mania, schizophrenia, or other psychoses; (b) current suicidal ideation; (c) current
alcohol or substance dependence; (d) inability to tolerate the virtual reality helmet; (e) history of
seizures.
The majority of the sample was female (n = 24, 60%), married (n =19, 48%), and well
educated (n = 27, 68%). The sample self-identified as “Caucasian” (n = 21, 54%), “AfricanAmerican” (n =12, 28%), “Latino” (n = 2, 4%), and “Asian American” (n = 2, 6%). The
remaining 3 participants reported “other” racial/ethnic identities.
2.2. Measures
The following measures were used to assess social phobia symptoms and presence.
2.2.1 Igroup Presence Questionnaire (IPQ; Schubert et al., 2001): The IPQ is a 14-item selfreport questionnaire designed to assess presence. Items are scored on a 7-point likert scale (1-7)
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with higher scores indicating a greater sense of presence. The IPQ can be used as a composite
measure of presence with scores ranging from 7 to 98 or it can be divided into subscales
assessing the three components of presence (spatial presence, involvement, and realness). The
spatial presence scale contains five items assessing feelings that one is physically within a virtual
environment (e.g., “I had a sense of acting in the virtual space, rather than operating something
from outside.”). The involvement subscale contains four items assessing attention to the virtual
world (e.g., “I was completely captivated by the virtual world.”). The realness subscale contains
four items assessing how real the virtual stimuli appear (e.g., “How real did the virtual world
seem to you?”). The measure has good psychometric properties and a factor structure that has
been replicated across multiple samples (Schubert et al., 2001). In the current study, the IPQ was
administered at the end of sessions in which exposure was conducted (session 5 to 8).
2.2.2 Personal Report of Confidence as a Speaker (PRCS; Paul, 1966): The PRCS is a 30-item
self-report questionnaire that assesses behavioral and cognitive responses to public speaking.
Sample items include “My hands tremble when I try to handle objects on the platform” and
“While preparing a speech, I am in a constant state of anxiety.” Answers are recorded in a
True/False format with summary scores ranging from 0-30 such that higher scores indicate
greater fear of public speaking. The PRCS has been shown to be moderately to strongly
correlated with broader measures of social phobia (Daly, 1978). Prior research with a large
normative sample indicated that PRCS scores do not differ across demographic variables
including age, ethnicity, and gender (Phillips, Jones, Rieger, & Snell, 1997). Additionally,
research that has used the PRCS as an outcome measure has shown it be sensitive to change for
exposure based interventions (Altmaier, Ross, Leary, & Thornbrough, 1982; Kirsch & Henry,
1977; Lawm, Schwartz, Houlihan, & Cassisi, 1994).
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2.2.3 Subjective Unit of Discomfort Scale (SUDS): The SUDS rating scale is a self-report
measurement of anxiety on a 0 to 100 point scale. Scores of 0 represent no fear and 100
represents the most fear the individual has ever felt. The therapist recorded peak SUDS ratings
during each virtual reality exposure treatment session.
2.2.4 Structured Clinical Interview for the DSM-IV (SCID; First et al., 2002): The SCID is a
structured, well-validated diagnostic clinical interview used to assess psychological disorders
based upon DSM-IV criteria. For the current project, the SCID was used to determine
participation eligibility as well as presence of a variety of Axis I conditions within the mood,
alcohol/substance use, and anxiety disorders modules.
2.3 Procedure
Data for the present study were collected through two treatment trials for a total of N =
41. The first, a randomized controlled trial, compared cognitive behavioral group therapy to VRE
to a WL control for social phobia. Only data from the participants who received VRE are
included in the present study (n=31). The second trial (n=10) examined amygdala activity as a
predictor of treatment response to VRE using functional magnetic resonance imaging (fMRI).
For the purposes of the present study, the procedures are the same across the two trials, with the
exception that participants in the fMRI trial were not randomly assigned to treatment; they all
received VRE. Figures 1 and 2 were prepared in accordance with guidelines outlined in the
CONSORT (Consolidated Standards of Reporting Trials; Altman et al., 2001) and TREND
(Transparent Reporting of Evaluations with Nonrandomized Designs; Des Jarlais, Lyles, Crepaz,
& the TREND Group, 2004) statements. Figure 1 and Figure 2 show the flow of VRE
participants through Trial 1 and Trial 2.
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Setting and Personnel. All procedures for this study were conducted at the Psychology
Clinic at Georgia State University and were approved by the University’s Institutional Review
Board. Four doctoral candidates in clinical psychology conducted all assessment procedures,
including telephone screening and in-person assessments under the supervision of a licensed
clinical psychologist. Treatment was administered by five study therapists, two senior therapists
were licensed psychologists with prior experience implementing manualized cognitive behavior
therapy and three junior therapists were doctoral students. Prior to administering therapy, study
therapists attended two-day intense training workshops, led by the developer of the treatment.
Junior therapists were supervised by the last author.
2.3.1 Assessments. Eligibility was determined through a two-part process, involving a
brief telephone screening and an in-person, pre-treatment assessment. During the phone screen,
potential participants were asked questions to rule out obvious exclusion criteria (e.g., began
psychoactive medication within the past 3 months). Following the phone screen, interested and
eligible individuals were scheduled for face-to-face pre-treatment assessment, which included
administration of the SCID and self-report measures. Participants completed the PRCS at pretreatment, mid-treatment, and post-treatment assessments. The IPQ was administered at the end
of each exposure session (sessions 5-8).
2.3.2 Treatment. VRE consisted of eight sessions of individual therapy delivered
according to a treatment manual (Anderson et al., 2005). The treatment was designed to target
several processes shown to maintain social anxiety, including self-focused attention, negative
perceptions of self and others, perceptions of lack of emotional control, rumination, and realistic
goal setting for social situations. The first four sessions targeted these processes via use of
cognitive restructuring and videotape feedback exercises, but did not include exposures to any of
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the virtual environments. Sessions 5-8 consisted of exposure to various virtual environments.
These scenarios were presented via a head-mounted display (HMD) that consisted of a helmet
with headphones, goggles, and a tracker that allowed the virtual environment to move naturally
with the participant. The virtual reality (VR) scenarios included 1) a conference room
(approximately 5 audience members), 2) a classroom (approximately 35 audience members), and
3) a large auditorium (approximately 100 audience members). VRE therapists could manipulate
audience reactions (e.g., making them appear interested/bored, supportive/hostile, distracted), as
well the difficulty of questions posed by audience members, according to each client’s treatment
goals.
3. Results
Descriptive statistics for all variables can be found in Table 1. A preliminary comparison
suggested that pretreatment PRCS scores did not significantly differ across participants with
social phobia and those with social phobia: generalized subtype, F (1, 39) = 0.15, p = 0.70.
3.1. The relation between presence and anxiety.
Multilevel modeling (MLM) was used to examine how strongly IPQ scores related to the
experience of anxiety in session, as indicated by peak SUDS fear ratings. First, a model was
fitted that included level 1 fixed effects for intercept, slope, and IPQ scores (Table 2). The fixed
effect for slope was not significant, indicating that peak levels of fear did not change during the
course of treatment (β 10 = 0.12, p = 0.44), but the fixed effect for IPQ scores was significant (β 20
= 0.09, p < 0.01). This suggests that, after controlling for slope, overall presence was positively
associated with peak fear ratings. To further explore the relation between presence and in-session
fear, a similar model was constructed that included fixed effects for the IPQ subscales (spatial
presence, involvement, and realness) instead of the total score. These findings indicated that
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after controlling for slope, realness was significantly related to peak fear ratings (β 40 = 0.22, p <
0.01), but spatial presence (β 20 = 0.02, p = 0.84) and involvement (β 30 = 0.01, p = 0.81) were not.
3.2. Associations between presence and treatment response.
A repeated measures ANOVA was conducted to compare IPQ scores across exposure
therapy sessions. Findings indicated that IPQ scores did not differ over time, F (3, 37) = 1.07, p
= 0.37. Similar findings were obtained for the spatial presence, F (3, 37) = 2.11, p = 0.68,
involvement, F (3, 37) = 2.48, p = 0.21, and realness subscales, F (3, 37) = 0.08, p = 0.97. Based
on these findings, mean IPQ and the IPQ subscale scores from the four sessions in which
exposure was conducted were used to examine the association between presence and treatment
response.
A multilevel model that included a fixed effect for intercept and slope at level 1 and total
IPQ scores at level 2 was fitted to examine how strongly presence predicted the rate of change
during the course of treatment (Table 3). These findings suggested that PRCS scores declined
during the course of treatment (β 10 = -3.79, p < 0.01). However, total IPQ scores were unrelated
to the rate of change (β 11 = -0.07, p = 0.16).
A similar model was used to examine the association between the IPQ subscales and
treatment response (Table 3). The subscales were entered as level 2 fixed effects for slope of
PRCS scores. Findings indicated that the involvement scale was associated with an increased rate
of change (slope; β 12 = -0.40, p < 0.01), but the spatial presence (β 11 = 0.20, p = 0.24) and
realness scales were not (β 13 = 0.14, p = 0.46). The involvement scale alone accounted for 9%
of the variance in the slope of PRCS scores. These findings indicate that the involvement
component of presence related to changes in social phobia symptoms from pretreatment to
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posttreatment but the overall construct of presence, as well as the spatial presence and realness
components, were not.
4. Discussion
Findings from the current study suggest that different components of presence are
associated with the experience of fear and treatment response to VRE. Total presence scores
were significantly associated with peak self-reported fear ratings during VRE; however, this
association appeared to be driven largely by a significant relationship between the realness
component of presence and fear ratings during exposure. In contrast, the involvement scale was
the only component that was significantly associated with treatment response.
Findings that peak within session fear ratings were associated with the overall construct
of presence and the realness subscale are consistent with prior research demonstrating a positive
association between presence and anxiety towards virtual stimuli (Krijn, Emmelkamp, Olafsson,
& Biemond, 2004; Price & Anderson, 2007). Emotional processing theory indicates that a
stimulus must be able to activate the fear structure if successful extinction learning is to take
place (Foa & Kozak, 1986). The association found in this and prior studies suggest that presence
is the mechanism by which a virtual stimulus can elicit fear and allow extinction learning to
occur. Given the correlational nature of the present study, as well as the use of retrospective
reports taken at the end of each session to measure presence, conclusions about the direction of
this relation cannot be drawn. It is possible that proneness to experience presence, particularly
its realness component, leads to higher ratings of fear during exposure therapy. Alternatively,
elevated levels of fear during exposure may lead participants to report later that they felt more
connected with the virtual environment and that it appeared more realistic. Additional research
using “on-line” measures of presence during actual exposure sessions are necessary to better
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understand how presence and fear relate to each other during VRE at both temporal and
conceptual levels.
With regard to the relation between presence and treatment response, only scores on the
involvement scale predicted response to VRE treatment for public speaking fear. The
involvement subscale provides a measure of how closely the participant focused on the virtual
environment and ignored distracting information from other sources during exposure (Schubert
et al., 2001). Findings of the current study are consistent with other research demonstrating that
sustained attention during exposure is associated with improved response, and distraction is
associated with poorer response (Kamphuis & Telch, 2000; Telch et al., 2004), as well as work
showing that an avoidant attention bias at the start of treatment was associated with reduced
outcomes in those with social phobia (Price, Tone, & Anderson, In press). These findings were
presumed to be attributed to the reduced availability of cognitive resources for extinction
learning because of distraction. Although not directly tested, the same explanation could apply
to the current study. During VRE, participants reporting higher involvement were better able to
focus on the virtual environment and ignore incongruent information from outside the virtual
environment. Such individuals may therefore have been less likely to have divided attentional
resources, leaving them with more attentional capacity to devote to extinction learning.
These findings have implications for clinical work. Clinicians using VRE to treat social
phobia should try to maximize a client’s presence within the virtual environment. Past research
has highlighted the importance of contextual cues in the acquisition of extinction learning
(Bouton, 2004; Bouton, Westbrook, Corcoran, & Maren, 2006). VRE provides an excellent
means to expose the participant to multiple contexts without leaving the therapist’s office.
Results from the current study suggest that maximizing presence for each context may increase
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the amount of fear experienced and maximizing involvement, or attentional focus, may lead to
better treatment response. At a practical level, this suggests that VRE therapists may achieve
better results by turning off lights in the office to reduce distraction from outside the virtual
environment. Prior research has shown that increasing the number of phobic elements, or salient
aspects of feared stimuli, in virtual environments is associated with increased reports of presence
(Price & Anderson, 2007; Ravaja et al., 2006). Asking clients to dress as they would when giving
a presentation or to hold common presentation props such as pointers may be helpful in
enhancing the VRE experience. Also, feared aspects that are specific to each client should be
replicated during the exposures to enhance a sense of presence.
Scores on the spatial presence subscale showed consistently nonsignificant associations
with in-session fear and treatment response. This suggests that spatial presence, the sense of
being in the virtual world, may be less important for both the experience of and successful
response to VRE than other components of presence. Alternatively, because public speaking
scenarios, which place the participant at the front of the audience as a speaker, were the only
virtual environment used in the present study, it is possible that the implied physical distance
between the participant and the audience members may have reduced participants’ feeling that
they were physically present in an actual room. Furthermore, public speaking scenarios typically
involve less interaction with virtual audience members than do other types of social interaction
scenarios, such as conversations. Thus, the implied physical distance from audience members
may have attenuated associations between spatial presence and both the experience of fear, and
treatment response. Additional research is needed to assess the association between these
variables in virtual environments (e.g., conversations or parties) that place participants in close
proximity and sustained interactions with virtual peers.
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The current study contained several limitations of note. First, the study relied exclusively
on self-report measures of public speaking fear and presence. Future work should assess how
presence is associated with physiological indicators of public speaking fear such as skin
conductance levels and heart rate. Also, sample size for the current study was relatively small (N
= 41). Although this is the largest sample of individuals with social phobia to receive VRE in the
literature thus far, the inconsistency of the present findings with prior research in samples with
specific phobia highlights the need for replication with larger samples before firm conclusions
can be drawn about presence and treatment response. Third, the current study exclusively used
public speaking scenarios, which constitute only one specific type of social interaction. As a
result, we do not know the effects of presence on decreases in fears for other social situations.
This is important because a recent review (Blöte, Kint, Miers, & Westenberg, 2009) questioned
the utility of speech tasks for assessing social anxiety symptoms, and suggested that public
speaking anxiety may be a specific subtype of social phobia. Additional research is needed to
determine how these subscales may be associated with treatment response for other types of
social interactions such as conversations, social settings such as parties, or other types of
evaluative environments, as much of the research using VRE to treat social phobia has focused
on addressing public speaking fears (Anderson et al., 2005; Harris et al., 2002; Klinger et al.,
2005). Virtual reality provides an excellent method by which to treat a variety of social fears due
to the flexibility of the system in that it can portray a range of environments. The therapist can
access a number of different social environments and interaction types to better tailor the
exposure to the needs of the individual.
Despite these limitations, findings of the current study are consistent with prior research
demonstrating that presence, particularly its realness component, is associated with the
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experience of fear during VRE. It is the first study to show that presence (or any aspect of
presence) is related to treatment response. The finding that a particular aspect of presence,
involvement, is associated with treatment response converges with proposed mechanisms of
exposure therapy.
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Table 1.
Descriptive statistics for presence and social phobia measures.

23.98 (3.11)

Midtreatment
(Session 5)
22.69 (4.35)

IPQ

-

56.77 (9.80)

57.16 (11.13)

57.44 (11.22)

55.38 (13.98)

Spatial Presence

-

20.33 (3.04)

20.54 (3.02)

20.11 (2.23)

20.73 (3.33)

Involvement

-

16.39 (4.37)

17.38 (5.58)

18.04 (5.21)

16.12 (6.22)

Realness

-

15.17 (4.59)

14.81 (4.76)

14.68 (5.00)

13.88 (5.98)

Pretreatment
PRCS

Session 6

Session 7

-

-

Posttreatment
(Session 8)
16.42 (7.26)

Note: PRCS = Personal Report of Confidence as a Speaker. IPQ = Igroup Presence
Questionnaire. Values in parentheses are standard deviations.
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1

Table 2.
MLM using IPQ and IPQ subscales as a predictor of slope for peak SUDS ratings across session
5 through 8.
Parameter

SUDS

Level 1
Intercept

β 00i

1.59 (1.57)

Slope

β 10i

-0.12 (0.15)

IPQ Total Score

β 20i

0.09** (0.02)

Intercept

β 00i

2.65 (2.08)

Slope

β 10i

-0.10 (0.15)

IPQ Spatial subscale

β 20i

0.02 (0.10)

IPQ Involvement subscale

β 30i

0.01 (0.05)

IPQ Realness subscale

β 40i

0.22** (0.05)

Level 1

Note: ** = p < 0.01. PRCS = Personal Report of Confidence as a Speaker. IPQ = Igroup
Presence Questionnaire. Values in parentheses are standard errors.
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Table 3.
MLM using mean IPQ and mean IPQ subscales as a predictor of slope for PRCS
Parameter

PRCS

Level 1
Intercept

β 00i

38.88** (1.14)

Slope

β 10i

-3.79** (0.55)

IPQ Total Score

β 11i

-0.07 (0.05)

Intercept

β 00i

25.68** (0.56)

Slope

β 10i

-4.18** (0.57)

IPQ Spatial subscale

β 11i

0.20 (0.16)

IPQ Involvement subscale

β 12i

-0.40** (0.13)

IPQ Realness subscale

β 13i

0.13 (0.18)

Level 2

Level 1

Level 2

Note: ** = p < 0.01. PRCS = Personal Report of Confidence as a Speaker. IPQ = Igroup
Presence Questionnaire. Values in parentheses are standard errors.
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Completed Phone
Screen (n = 191)

Eligible for Pre-tx
Assessment
(n = 157)

•
•

3

Excluded (n = 59)
Not meeting inclusion criteria,
excluded at pre-tx assessment (18)
Did not attend pre-tx assessment (41)

Fulfilled Inclusion
Criteria
Randomized to
Treatment
(n = 97)

Allocated to comparison treatment
(n = 40). No further data is
presented, as it is not relevant to
the current study

Allocated to WL (n = 29)
• Dropped WL (4)

Completed WL
(n =25)

Dropped after WL (3)

Allocated to VRE (n = 29)
• Dropped VRE ()
o Prior to Tx (0)
o After Beginning Tx (4)

Completed VRE
(n =25)

Randomized to VRE (n = 11)
• Dropped VRE (5)
o Prior to Tx (2)
o After beginning Tx (3)

Study 1 Total VRE Completers (n = 31)
Study 1Total VRE Enrolled (n = 40)

Figure 1. Flow of participants through Study 1, RCT.
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Assessment
(n = 26)
•
Attended Pre-tx
assessment
(n = 19)
•
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T
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Fulfilled Inclusion
Criteria
Assigned to
Treatment
(n = 14)

Assigned to VRE (n
=14)
• Dropped VRE (4)
o Prior to Tx (2)
o After beginning
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T
T
X

Did not attend pre-tx
assessment (7)

Study 2 Total VRE
Completers
(n =10)

Figure 2. Flow of participants through Study 2, fMRI clinical trial.

Excluded (n = 5)
Not meeting inclusion
criteria, excluded at pre-tx
assessment (5)
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Figure 3. Treatment response for PRCS at +/- 1 standard deviation of the involvement subscale
of the IPQ.
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